Both in Pharmaceuticals
Harmony Biosciences Holdings vs Sarepta Therapeutics,
Over the past year HRMY returned +12.0% and SRPT returned +17.2%; their daily moves had a correlation of 0.30.
HRMY +12.0% SRPT +17.2%Growth of $1, one year, split-adjusted
| Metric | HRMY | SRPT |
|---|---|---|
| Price | $34.42 | $18.99 |
| Market cap | $2.00B | $2.01B |
| Today | −7.04% | +2.43% |
| 1 month | −12.6% | +9.7% |
| 6 months | +5.0% | −17.5% |
| Year to date | −8.0% | −11.8% |
| 1 year | +17.3% | −22.3% |
| Revenue growth (YoY) | +30.3% | −34.3% |
| Gross margin | 75.8% | 62.8% |
| Net margin | 28.9% | −1.2% |
| P/E (TTM) | 11.1× | — |
| Price / sales | 2.1× | 1.0× |
| Net cash | $513.8M | -$59.1M |
| Dividend yield | — | — |
| Volatility (60d) | 35.9% | 61.6% |
| Short % of float | 11.8% | 22.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).